发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Marstacimab (Hympavzi) for hemophilia A and B. 马司他单抗（Hympavzi）用于血友病A和B。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717b
{"title":"Marstacimab (Hympavzi) for hemophilia A and B.","authors":"","doi":"10.58347/tml.2024.1717b","DOIUrl":"https://doi.org/10.58347/tml.2024.1717b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"198-199"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zolbetuximab (Vyloy) for gastric and gastroesophageal carcinoma. Zolbetuximab （Vyloy）治疗胃癌和胃食管癌。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717g
{"title":"Zolbetuximab (Vyloy) for gastric and gastroesophageal carcinoma.","authors":"","doi":"10.58347/tml.2024.1717g","DOIUrl":"https://doi.org/10.58347/tml.2024.1717g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"e204-e205"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isatuximab (Sarclisa) for multiple myeloma. Isatuximab （Sarclisa）治疗多发性骨髓瘤。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717e
{"title":"Isatuximab (Sarclisa) for multiple myeloma.","authors":"","doi":"10.58347/tml.2024.1717e","DOIUrl":"https://doi.org/10.58347/tml.2024.1717e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"e200-e201"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inavolisib (Itovebi) for locally advanced or metastatic breast cancer. 治疗局部晚期或转移性乳腺癌的伊那韦利（Itovebi）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715f
{"title":"Inavolisib (Itovebi) for locally advanced or metastatic breast cancer.","authors":"","doi":"10.58347/tml.2024.1715f","DOIUrl":"https://doi.org/10.58347/tml.2024.1715f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"e186-e187"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axatilimab (Niktimvo) for chronic graft-versus-host disease. 阿沙替利单抗（Niktimvo）治疗慢性移植物抗宿主病。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715e
{"title":"Axatilimab (Niktimvo) for chronic graft-versus-host disease.","authors":"","doi":"10.58347/tml.2024.1715e","DOIUrl":"https://doi.org/10.58347/tml.2024.1715e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"e184-e185"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xanomeline/Trospium (Cobenfy) for schizophrenia. 治疗精神分裂症的 Xanomeline/Trospium (Cobenfy)。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715a
{"title":"Xanomeline/Trospium (Cobenfy) for schizophrenia.","authors":"","doi":"10.58347/tml.2024.1715a","DOIUrl":"https://doi.org/10.58347/tml.2024.1715a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"177-179"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lebrikizumab (Ebglyss) for atopic dermatitis. 治疗特应性皮炎的 Lebrikizumab（Ebglyss）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715b
{"title":"Lebrikizumab (Ebglyss) for atopic dermatitis.","authors":"","doi":"10.58347/tml.2024.1715b","DOIUrl":"https://doi.org/10.58347/tml.2024.1715b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"179-181"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vorasidenib (Voranigo) for low-grade glioma. 治疗低级别胶质瘤的 Vorasidenib（Voranigo）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715g
{"title":"Vorasidenib (Voranigo) for low-grade glioma.","authors":"","doi":"10.58347/tml.2024.1715g","DOIUrl":"https://doi.org/10.58347/tml.2024.1715g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"e188-e189"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risankizumab (Skyrizi) for ulcerative colitis. 治疗溃疡性结肠炎的利桑珠单抗（Skyrizi）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715d
{"title":"Risankizumab (Skyrizi) for ulcerative colitis.","authors":"","doi":"10.58347/tml.2024.1715d","DOIUrl":"https://doi.org/10.58347/tml.2024.1715d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"182-184"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eroxon - an OTC gel for erectile dysfunction. Eroxon - 治疗勃起功能障碍的非处方药凝胶。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715c
{"title":"Eroxon - an OTC gel for erectile dysfunction.","authors":"","doi":"10.58347/tml.2024.1715c","DOIUrl":"https://doi.org/10.58347/tml.2024.1715c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"181-182"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信